Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Marsh

Showing results (491-500 of 654) with videos related to

Pageof 66
Sort By:
Substance Abuse Treatment, Prevention, and Policy|May 22, 2023
Building an inpatient addiction medicine consult service in Sudbury, Canada: preliminary data and lessons learned in the era of COVID-19Tara Leary, Natalie Aubin, David C Marsh, et al.
Addiction Science & Clinical Practice|October 7, 2015
Contribution of BDNF and DRD2 genetic polymorphisms to continued opioid use in patients receiving methadone treatment for opioid use disorder: an observational studyMonica Bawor, Brittany B Dennis, Charlie Tan, et al.
Journal of Pharmacological and Toxicological Methods|May 16, 2019
Increased stress associated with head-out plethysmography testing can exacerbate respiratory effects and lead to mortality in ratsJames J Lynch, Emilie Rossignol, Joerg J Moehrle, et al.
Journal of Neuroimmunology|September 14, 2011
Role of α7 nicotinic acetylcholine receptors in regulating tumor necrosis factor-α (TNF-α) as revealed by subtype selective agonistsJinhe Li, Suzanne L Mathieu, Richard Harris, et al.
Drug and Alcohol Dependence|February 24, 2020
The impact of chronic liver disease in patients receiving active pharmacological therapy for opioid use disorder: One-year findings from a prospective cohort studyBrittany B Dennis, Daud Akhtar, George Cholankeril, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1990
Metabolism and disposition of clarithromycin in manJ L Ferrero, B A Bopp, K C Marsh, et al.
CMAJ Open|October 13, 2015
Sex differences in outcomes of methadone maintenance treatment for opioid use disorder: a systematic review and meta-analysisMonica Bawor, Brittany B Dennis, Anuja Bhalerao, et al.
Addictive Behaviors Reports|June 13, 2018
The association between nicotine dependence and physical health among people receiving injectable diacetylmorphine or hydromorphone for the treatment of chronic opioid use disorderHeather Palis, Kirsten Marchand, Mohammad Karamouzian, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Cortical-layer EEG-fMRI at 7T: experimental setup and analysis pipeline to elucidate generating mechanisms of alpha oscillationsDaniel C Marsh, Rodika Sokoliuk, Kevin M Aquino, et al.
Journal of Biomedical Materials Research|November 1, 1975
Ultrathin coating by plasma polymerization applied to corneal contact lensH Yasuda, M O Bumgarner, H C Marsh, et al.
Pageof 66

Showing results (491-500 of 654) with videos related to

Sort By:
Pageof 66
Substance Abuse Treatment, Prevention, and Policy|May 22, 2023
Building an inpatient addiction medicine consult service in Sudbury, Canada: preliminary data and lessons learned in the era of COVID-19Tara Leary, Natalie Aubin, David C Marsh, et al.
Addiction Science & Clinical Practice|October 7, 2015
Contribution of BDNF and DRD2 genetic polymorphisms to continued opioid use in patients receiving methadone treatment for opioid use disorder: an observational studyMonica Bawor, Brittany B Dennis, Charlie Tan, et al.
Journal of Pharmacological and Toxicological Methods|May 16, 2019
Increased stress associated with head-out plethysmography testing can exacerbate respiratory effects and lead to mortality in ratsJames J Lynch, Emilie Rossignol, Joerg J Moehrle, et al.
Journal of Neuroimmunology|September 14, 2011
Role of α7 nicotinic acetylcholine receptors in regulating tumor necrosis factor-α (TNF-α) as revealed by subtype selective agonistsJinhe Li, Suzanne L Mathieu, Richard Harris, et al.
Drug and Alcohol Dependence|February 24, 2020
The impact of chronic liver disease in patients receiving active pharmacological therapy for opioid use disorder: One-year findings from a prospective cohort studyBrittany B Dennis, Daud Akhtar, George Cholankeril, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1990
Metabolism and disposition of clarithromycin in manJ L Ferrero, B A Bopp, K C Marsh, et al.
CMAJ Open|October 13, 2015
Sex differences in outcomes of methadone maintenance treatment for opioid use disorder: a systematic review and meta-analysisMonica Bawor, Brittany B Dennis, Anuja Bhalerao, et al.
Addictive Behaviors Reports|June 13, 2018
The association between nicotine dependence and physical health among people receiving injectable diacetylmorphine or hydromorphone for the treatment of chronic opioid use disorderHeather Palis, Kirsten Marchand, Mohammad Karamouzian, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Cortical-layer EEG-fMRI at 7T: experimental setup and analysis pipeline to elucidate generating mechanisms of alpha oscillationsDaniel C Marsh, Rodika Sokoliuk, Kevin M Aquino, et al.
Journal of Biomedical Materials Research|November 1, 1975
Ultrathin coating by plasma polymerization applied to corneal contact lensH Yasuda, M O Bumgarner, H C Marsh, et al.
Pageof 66